Sleep apnea is a common problem affecting daily functioning and health. We evaluated associations between sleep apnea and receipt of a disability pension and mortality in a prospective study of 74,543 cases of sleep apnea (60,125 outpatient, 14,418 inpatient) from the Swedish Patient Register (2000-2009 inclusive). Cases were matched to 5 noncases (n = 371,592) and followed from diagnosis/inclusion to December 31, 2010, via nationwide registers. During a mean follow-up period of 5.1 (standard deviation, 2.7) years, 13% of men and 21% of women with inpatient sleep apnea received a disability pension. Inpatient sleep apnea was associated with higher total mortality (for men, hazard ratio (HR) = 1.71, 95% confidence interval (CI): 1.59, 1.84; for women, HR = 2.33, 95% CI: 2.04, 2.67), with associations being strongest for deaths due to ischemic heart disease (for men, HR = 2.27, 95% CI: 1.94, 2.65; for women, HR = 5.27, 95% CI: 3.78, 7.34), respiratory disorders (for men, HR = 3.29, 95% CI: 2.45, 4.42; for women, HR= 5.24, 95% CI: 3.52, 7.81), and suicide (for men, HR = 1.76, 95% CI: 1.19, 2.60; for women, HR = 4.33, 95% CI: 1.96, 9.56). There were no associations of inpatient sleep apnea with cancer mortality. Outpatient sleep apnea was associated with a higher risk of receiving a disability pension but not higher total mortality. In conclusion, inpatient sleep apnea is related to a higher risk of disability pension receipt and mortality a decade after diagnosis.
Sleep apnea is a very common but highly underdiagnosed and undertreated condition (1) . Obstructive sleep apnea, the most common type of sleep apnea, is characterized by frequent breathing pauses which result in repeated reversible blood oxygen desaturation and fragmented sleep (2) . It is estimated that 10%-17% of middle-aged men and 3%-9% of middle-aged women suffer from moderate-to-severe sleep apnea, defined as stopping breathing 15 or more times per hour during sleep, and the prevalence is increasing (3) .
Sleep apneics have problems with concentration, attention, and cognitive function, with performance being inversely related to the level of sleep disruption (4) . Such problems underlie the higher rates of motor vehicle accidents and occupational accidents among people with sleep apnea (5) . Prospective studies have provided evidence of associations between sleep apnea and incidence of cardiovascular disease (CVD) (6) (7) (8) , and there is increasing evidence of associations between sleep apnea and insulin resistance, glucose intolerance, and type 2 diabetes (9) .
Very few studies have examined the associations between sleep apnea and work performance outcomes (10) (11) (12) (13) , which may be directly related to attention problems and cognitive functioning (4) . Receipt of a disability pension is also known to be a risk marker for premature death (14) . A Norwegian study of 7,000 persons showed symptoms of sleep apnea to be associated with long-term sick leave and permanent work disability (10) . These findings are supported by a study in which sleep apnea was identified using polysomnography (11) and by a case-control study using hospital discharge records and data on sickness absence and disability pensions from national registers (13) . In further analyses from the case-control study, a higher risk of sickness absence was observed up to 5 years prior to diagnosis of sleep apnea (12) .
Few population-based studies have addressed whether sleep apnea affects overall mortality risk, and they have rather consistently found higher risks of all-cause (15) (16) (17) and CVD (16, 18 ) mortality among persons with moderate-to-severe sleep apnea as compared with those without sleep apnea. In one of the larger population-based studies, which included 6,441 men and women, Punjabi et al. (19) found severe sleep apnea to be associated with a modestly higher mortality risk, with some suggestion of age and sex differences in the associations.
To provide a comprehensive picture of the public health burden associated with sleep apnea, we aimed to examine the relationship between sleep apnea and both employability (defined as receipt of a disability pension) and mortality in nationwide data for Sweden. The present study included more than 74,000 sleep apnea cases, and we had sufficient statistical power to examine the hypothesized relationships and consider multiple adjustments. We also distinguished between inpatient and outpatient cases, which may differ in terms of severity and comorbidity.
METHODS

Study population
Everyone in Sweden has a unique personal identification number which permits exact data linkage between nationwide public registers administered by Statistics Sweden. The population sample for this study was nested within a cohort of the 5,587,922 persons aged 16-64 years who were living in Sweden on December 31, 1999. Within this cohort, all cases of sleep apnea diagnosed between 2000 and 2009 (both years inclusive) were identified in the Swedish Patient Register, which covers both inpatient visits and, since 2001, specialized outpatient visits. Specialized clinics include ambulatory sleep clinics affiliated with a hospital. The project was approved by the Regional Ethical Review Board of Stockholm, Sweden. To ensure a focus on incident sleep apnea, everyone who had received a diagnosis of sleep apnea during the 3 years prior to 2000 (n = 8,489) was excluded. A total of 74,867 incident cases with a diagnosis of sleep apnea were identified in the Patient Register during this period. Unfortunately, the coding system of the International Classification of Diseases does not allow for a distinction between central sleep apnea and obstructive sleep apnea. We chose the earliest hospital admission or outpatient visit with a diagnosis of sleep apnea as the index date.
A sleep apnea diagnosis in the Swedish health-care system is based on clinical criteria according to the International Classification of Diseases, Tenth Revision (ICD-10) (ICD-10 code G47.3) using the patient's medical history (anamnesis) combined with either polysomnography (i.e., continuous overnight recordings in a sleep laboratory) or in-home overnight respiratory polygraphy, which at a minimum records respiratory movement and air flow, heart rate or electrocardiography, and oxygen saturation, measured by a portable ambulatory device (20) . Polygraphy is a cost-effective alternative to polysomnography, which has shown high sensitivity and specificity for the diagnosis of sleep apnea (21) . The clinical criteria for sleep apnea are 1) ≥5 obstructive respiratory events (obstructive or mixed apneas, hypopneas, or respiratory-effort related arousals) per hour of sleep as measured by polygraphy/polysomnography and either self-reported symptoms of sleep apnea or comorbidity or 2) ≥15 obstructive respiratory events per hour as measured by polygraphy/polysomnography, regardless of clinical symptoms. We distinguished between inpatient and outpatient sleep apnea diagnoses, as they may differ in terms of severity, complexity, and comorbidity. The majority of sleep apnea cases are diagnosed in specialized outpatient sleep clinics (i.e., outpatient diagnosis). Sleep apnea can also be diagnosed in hospitalized patients (i.e., inpatient diagnosis) when they are hospitalized for other reasons or because there is no specialized outpatient sleep clinic in their proximity. The same clinical criteria for diagnosis apply to both outpatient and inpatient diagnoses.
For each sleep apnea patient, a sex-matched random sample of 5 noncases was drawn from among those cohort members who were still alive and free of diagnosed sleep apnea on the case's index date (density sampling); this yielded a total of 374,335 controls. We chose to match by sex only, since we wanted to preserve the nationwide representative nature of the cohort. Persons lacking information on education (n = 3,067 (2,743 noncases and 324 cases)) were excluded from the analysis, which left a final study population of 74,543 sleep apnea cases (i.e., 60,125 outpatient cases and 14,418 inpatient hospital admissions) and 371,592 noncases. The study population was followed from baseline to emigration (n = 2,880), death, or the end of follow-up on December 31, 2010.
Covariates
Population-based information on years of education, family situation (married/living with a partner (without children); married/living with a partner (with children); single, separated, divorced, or widowed (without children); single, separated, divorced, or widowed (with children); or adolescent aged 16-20 years living with parent(s)), area of residence, and country of birth was obtained from Statistics Sweden, while information on comorbidity was obtained from the Swedish Patient Register. Comorbidity was defined as hospitalization with CVD (ICD-10 codes I00-I99 or G45), cancer (ICD-10 codes C00-C97), respiratory disorders (ICD-10 codes J00-J99), or diabetes (ICD-10 codes E10-E14) from 1997 onwards for inpatient visits and from 2001 onwards for outpatient visits in specialized care up to the index date for each sleep apnea case (baseline). All information on covariates was obtained at baseline, except for information on area of residence and country of birth, which was obtained for December 31, 1999 .
Receipt of a disability pension "Disability pension" was defined as being granted a disability pension or having an ongoing sick-leave episode that had lasted for 2 years or more, as registered by the Social Insurance Agency. For the analyses of disability pensions, we excluded persons aged ≥65 years at baseline (n = 36,979) and those who were already on a disability pension (n = 41,269) or longterm sick leave (≥2 years) (n = 3,716) at baseline, leaving 53,226 sleep apnea cases and 310,945 noncases for the analyses of disability pensions. Once people reach official retirement age they are no longer at risk of a disability pension, so follow-up for the analyses of disability pensions was censored at age 65 years (the official retirement age in Sweden). In Sweden, everyone with an income from work or unemployment benefits is covered by the public sickness absence scheme, and everyone aged 19-64 years, including those with no previous income, is covered by the public disability pension scheme if their work capacity is reduced permanently due to disease or injury. During the years studied, the right to a disability pension was supposed to be assessed after 12 months of sickness absence, but in reality it was often done much later. Therefore, we included persons who had been out on sick leave for 2 or more years in the definition of a disability pension.
Total and cause-specific mortality
The National Cause-of-Death Register uses the ICD-10 codes. The most common main causes of death and those expected to be more strongly related to sleep apnea were included in the cause-specific analyses: CVD (ICD-10 codes I00-I99 and G45), including ischemic heart disease (ICD-10 codes I20-I25) and stroke (ICD-10 codes I60-I69 and G45), cancer (ICD-10 codes C00-C97), respiratory diseases (ICD-10 codes J00-J99), and external causes (ICD-10 codes V01-Y98), including suicide (ICD-10 codes X60-X84).
Statistical methods
Cox proportional hazards models with time since diagnosis/ index date as the underlying time variable were used to analyze the data (22) . All variables met the assumption of proportional hazards. Initially, we estimated age-adjusted hazard ratios and 95% confidence intervals for receipt of a disability pension and mortality according to sleep apnea separately for men and women. A multiply adjusted model was fitted to adjust for confounding from baseline covariates. Results of all analyses were adjusted for existing morbidity at the time of diagnosis. However, because sleep apnea can go unrecognized for many years, undiagnosed sleep apnea may already have resulted in existing comorbidity at baseline and thereby been a potential mediator of the association between sleep apnea and the study endpoints. Because adjusting for such comorbidity could have constituted overadjustment, we adjusted for existing comorbidity in separate analyses.
Secondly, we addressed the association between inpatient sleep apnea and total and CVD mortality in analyses stratified by age, educational level, family situation, and comorbidity from CVD, diabetes, or respiratory disorders in order to identify vulnerable subgroups. Results of the stratified analyses were adjusted for all other potentially confounding factors. Since hazard ratios cannot be directly compared across subgroups, because they relate to different baseline risks in each subgroup, the stratified Cox models were supplemented with results from an additive hazards model (23) . In this model, the hazard is modeled as a linear function of the explanatory variables so the estimates can be directly interpreted as the number of additional deaths associated with sleep apnea in each subgroup-a strategy that also enables the identification of patients for whom most cases could potentially be prevented (24) . We tested the underlying assumption of time-invariant associations and found no indication of violation. In a sensitivity analysis, we stratified the follow-up time into the first 2 years after diagnosis and 2 or more years after diagnosis to address both acute and longer-term associations. Additive hazards models were fitted using the free software package R (R Foundation for Statistical Computing, Vienna, Austria), version 2.13.1 (through the package "timereg," version 1.5). All other analyses were conducted using Stata (StataCorp LP, College Station, Texas), version 12.
RESULTS
Baseline characteristics
A total of 74,543 persons (approximately 1.3%) received an inpatient or outpatient diagnosis of sleep apnea during 2000-2009. Age at diagnosis ranged from 16 years to 73 years (mean = 46 years). Baseline characteristics of the population are shown in Table 1 . Sleep apnea cases with in-and outpatient diagnoses showed quite similar baseline characteristics, except that inpatient diagnoses were more common in big cities and that cases with an inpatient diagnosis as compared with an outpatient diagnosis were more likely to already be receiving a disability pension at the time of diagnosis.
Disability pensions
Six and one-half percent of men with an outpatient diagnosis of sleep apnea and 13% of men with an inpatient diagnosis were awarded a disability pension during follow-up. Equivalent percentages for women were 10.5% and 21%, respectively. Compared with those without sleep apnea, men with an outpatient diagnosis of sleep apnea were almost twice as likely to receive a disability pension (hazard ratio (HR) = 1.96, 95% confidence interval (CI): 1.87, 2.06), while men with an inpatient diagnosis showed a more than threefold higher risk of receiving a disability pension (HR = 3.34, 95% CI: 3.13, 3.57) ( Table 2 ). Associations with receipt of a disability pension in women were even stronger (for outpatient sleep apnea, HR = 2.41 (95% CI: 2.24, 2.60); for inpatient sleep apnea, HR = 4.51 (95% CI: 4.04, 5.03)).
Total mortality
During a mean follow-up time of 5.1 (standard deviation (SD), 2.7) years (range, 0.5-10.9 years), 1,624 deaths occurred among outpatient cases, 1,066 deaths occurred among inpatient cases, and 7,551 deaths occurred among noncases. The mean age at the time of death was 60.5 (SD, 10.0) years (range, 19-75 years) for men and 61.6 (SD, 9.1) years (range, 21-75 years) for women. Cumulative survival curves for noncases and for patients with an out-or inpatient diagnosis of sleep apnea are presented in Figure 1 . Outpatient sleep apnea was not associated with higher mortality risk in either sex (Tables 3 and 4 ). In contrast, inpatient sleep apnea was associated with a higher risk of all-cause mortality in men (HR = 1.71, 95% CI: 1.59, 1.84) and in women (HR = 2.33, 95% CI: 2.04, 2.67). These associations were attenuated upon adjustment for comorbidity.
The association between inpatient sleep apnea and total mortality appeared to be strongest in younger age groups (Table 5 ). However, since associations based on the relative scale are not comparable across age groups due to much lower mortality rates in younger age groups, a different picture emerged when we examined associations on the absolute scale, where inpatient sleep apnea was associated with a markedly higher number of premature deaths in the older (compared with the younger) age groups. The relative mortality risks associated with inpatient sleep apnea appeared to be similar across educational levels and family situations, although the absolute number of premature deaths associated with inpatient sleep apnea was larger among persons with a low educational level and those who were single, due to a generally higher mortality risk in these groups. The association between inpatient sleep apnea and premature mortality seemed to be confined to persons with existing comorbidity; there were 811 (95% CI: 633, 989) additional deaths per 100,000 person-years.
Sensitivity analyses showed that 300 of the 1,066 deaths taking place among inpatient sleep apnea cases during follow-up occurred within the first 2 years of diagnosis. Associations were slightly stronger during this period; hazard ratios were 2.31 (95% CI: 2.01, 2.65) for men and 2.88 (95% CI: 2.25, 3.68) for women (data not shown). However, after exclusion of the first 2 years of follow-up, mortality risk remained high in both men (HR = 1.55, 95% CI: 1.42, 1.69) and women (HR = 2.16, 95% CI: 1.84, 2.54).
CVD mortality
A total of 2,323 men and 426 women died from CVD during follow-up. Outpatient sleep apnea was associated with a slightly higher risk of CVD mortality in men (HR = 1.29, 95% CI: 1.16, 1.42), but not in women (HR = 1.05, 95% CI: 0.80, 1.37). In contrast, inpatient sleep apnea was associated with a markedly higher risk of CVD mortality in both men (HR = 2.42, 95% CI: 2.16, 2.73) and women (HR = 4.19, 95% CI: 3.30, 5.32). These associations were most pronounced for ischemic heart disease and persisted after adjustment for comorbidity. Inpatient sleep apnea was associated with a greater number of additional CVD deaths in older age groups, persons with less education, and single persons (Table 5 ). As expected, the strongest association between inpatient sleep apnea and CVD mortality was found for persons with existing comorbidity at baseline, but an association remained among those without such comorbidity (HR = 1.66, 95% CI: 1.37, 2.02), equivalent to 58 (95% CI: 23, 98) additional CVD deaths per 100,000 years among inpatient sleep apnea cases compared with noncases.
Death due to other causes
Inpatient, but not outpatient, sleep apnea was associated with a markedly higher risk of death due to respiratory disorders in men (HR = 3.29, 95% CI: 2.45, 4.42) and women (HR = 5.24, 95% CI: 3.52, 7.81) (Tables 3 and 4) . Again, these associations were attenuated but remained significant after adjustment for existing comorbidity. Persons with an inpatient diagnosis of sleep apnea were also found to be at higher risk of death due to external causes. Although the finding was based on few cases, this association was most pronounced for suicide in men (HR = 1.76, 95% CI: 1.19, 2.60) and women (HR = 4.33, 95% CI: 1.96, 9.56). There were no clear associations between inpatient sleep apnea and cancer mortality in either men (HR = 1.03, 95% CI: 0.89, 1.20) or women (HR = 1.04, 95% CI: 0.79, 1.37). Interestingly, women (HR = 0.80, 95% CI: 0.67, 0.97) and men (HR = 0.89, 95% CI: 0.80, 0.99) with an outpatient diagnosis of sleep apnea even seemed to be at slightly lower risk of cancer mortality.
DISCUSSION
In a large, register-based cohort study covering all sleep apnea cases diagnosed during a 10-year period among people of working age in Sweden, we found both inpatient care and specialized outpatient care involving sleep apnea to be associated with a higher risk of future receipt of a disability pension. Thirteen percent of the men and 21% of the women with an inpatient diagnosis of sleep apnea received a disability pension over an average follow-up period of 5 years. We also found a noticeably higher risk of premature death among persons with an inpatient diagnosis of sleep apnea as compared with noncases. In absolute numbers, the association between inpatient sleep apnea and risk of premature death was most pronounced in older age groups and among persons with existing comorbidity, those with less education, and those who were single. The association between inpatient sleep apnea and premature death was primarily due to a higher risk of deaths due to CVD, respiratory disorders, and suicide. We found no evidence of a higher mortality risk among outpatient sleep apnea cases. Neither inpatient nor outpatient sleep apnea was associated with a higher risk of cancer death.
We found a higher risk of disability pension receipt among both men and women with sleep apnea. In line with our results, another large register-linkage study from Denmark showed that patients with an inpatient diagnosis of sleep apnea had more contacts with the health-care system, more medication use, and higher unemployment rates than the general population (25) . A Norwegian study based on 7,028 middle-aged persons also found self-reported symptoms of sleep apnea to predict longterm sick leave and work disability (10) . In Finland, inpatient sleep apnea cases were found to have a nearly 2-fold higher risk of lost workdays due to work-related disability during the 5-year period preceding diagnosis (12) . Our study is by far the largest study to date to have addressed the association between sleep apnea and mortality, and our results are generally in line with those previously reported. For example, a community-based study including 397 participants and 77 deaths among middle-aged men and women showed moderate-to-severe sleep apnea to be associated with a 4-fold higher risk of mortality (15) , and a population-based study of 1,522 men and women with 80 deaths showed severe sleep apnea, determined by polysomnography, to be associated with a 3-fold higher risk of allcause mortality and a higher risk of CVD mortality (16) . One of the few larger population-based studies (6,441 participants) also showed a modestly higher risk of all-cause mortality among severe sleep apnea cases (19) .
Our findings cannot be directly compared with those of clinical studies, but previous prospective clinic-based studies have found results similar to those for mortality in the present study. For example, a clinic-based US study including 1,022 patients showed that patients with sleep apnea had twice the risk of stroke and all-cause mortality as those without apnea (17) . Another clinic-based study of 1,116 female patients from Spain showed that untreated severe obstructive sleep apnea was associated with a 3-fold higher risk of CVD mortality (18) .
The register-based design of our study provided us with a large representative study sample drawn from the entire Swedish population and information on sleep apnea diagnoses from the Swedish Patient Register, which is known for its good coverage (26) . However, sleep apnea often goes undiagnosed for years, and it has been estimated that as many as 75% of severe apnea cases remain undiagnosed (27) . Further, the diagnosis is often made in primary care, which is not covered in the patient registry. Thus, including only those persons with a hospital or specialized-care diagnosis of sleep apnea may have resulted in considerable underestimation of the scope of the problem, and mild cases of sleep apnea may have been poorly represented in our study. However, because previous studies have found no clear associations between mild sleep apnea and higher risk of CVD or all-cause mortality (15, 16) , this may be of less concern. Although obstructive sleep apnea is by far the most common type of sleep apnea (28), we were also not able to distinguish between types of sleep apnea, which may affect mortality risk differently.
The observed differences in associations between inpatients and outpatients are puzzling. Inpatient sleep apnea cases may represent more severe and complicated cases of sleep apnea and as such be a proxy for severity. On the other hand, persons with an inpatient sleep apnea diagnosis may also be more likely to be under treatment for other chronic conditions, so an inpatient diagnosis may be a proxy for underlying morbidity. We adjusted our analyses for existing morbidity and found that the overall association between inpatient sleep apnea and mortality was attenuated-an observation which partly supports the comorbidity hypothesis. On the other hand, underlying morbidity is unlikely to have severely affected the risk estimates for death due to external causes, and, as expected, adjustment for existing comorbidity resulted in only a minor change in the associations. In addition, we found a higher risk of CVD mortality among the sleep apnea cases without existing comorbidity at baseline. Polygraphy may more often have been used as a diagnostic tool in outpatient clinics compared with inpatient care, but unfortunately the diagnostic details of the individual cases were not available in the registers. However, the sensitivity and specificity of polygraphy as compared with polysomnography are high (21) , and the same diagnostic criteria apply to both tools.
Diagnosed sleep apnea patients often receive treatment, and some smaller studies have shown a beneficial effect of treatment with continuous positive airway pressure (18, (29) (30) (31) , although there is some controversy due to the compliance bias apparent in many treatment studies (32) . It is a major limitation of the study that we were not able to distinguish between treatment types and take into account the potentially beneficial effect of sleep apnea treatment. This may have resulted in underestimation of the associations between sleep apnea and disability pensions/mortality. Finally, we were not able to adjust our analyses for healthrelated behavior or for obesity, which is associated with both the presence and the severity of sleep apnea (33) and a higher mortality risk (34) . However, smaller studies on sleep apnea and mortality have found no strong confounding by obesity or health-related behavior (15) (16) (17) (18) .
In conclusion, sleep apnea is a common and often treatable condition. Our results suggest that sleep apnea may be an important risk factor for premature death or have socioeconomic consequences, in terms of receipt of a disability pension, among people of working age.
